Overactive Bladder - Results from #60

REVIEW UroToday

Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis. July 12, 2024

Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL). July 7, 2024

The association between wet overactive bladder and consumption of tea, coffee, and caffeine: Results from 2005-2018 National Health and Nutrition Examination Survey. July 7, 2024

Relationship Between Overactive Bladder and Bone Fracture Risk in Female Patients. July 7, 2024

Botulinum toxin A for idiopathic overactive bladder in women. June 28, 2024

Results of a study examining the use of onabotulinumtoxinA in pediatric patients with overactive bladder. June 28, 2024

The exposure to volatile organic compounds associate positively with overactive bladder risk in U.S. adults: a cross-sectional study of 2007-2020 NHANES. June 28, 2024

Overactive bladder and cognitive impairment in middle-aged women: A cross-sectional study. June 21, 2024

Association between body roundness index and overactive bladder: results from the NHANES 2005-2018. June 21, 2024

Language, cultural adaptation and validation of the OABSS (Overactive Bladder Symptom Score) questionnaire in patients with overactive bladder. June 14, 2024

Topical estrogen therapy ameliorates bladder estrogen receptor β expression in female patients with overactive bladder. June 14, 2024

Association between life's essential 8 and overactive bladder. June 14, 2024

Prospective follow-up of overactive bladder symptoms in patients with prior SARS-CoV-2 infection. June 9, 2024

Intradetrusor Versus Suburothelial Onabotulinum Toxin A in Adults with Neurogenic and Non-neurogenic Overactive Bladder Syndrome: A Meta-Analysis. June 9, 2024

Increased prevalence of metabolic syndrome in female patients with overactive bladder: A population-based study. June 9, 2024

Efficacy of transcutaneous electrical nerve stimulation combined with mirabegron therapy compared with mirabegron monotherapy for overactive bladder: a prospective randomized controlled study. June 9, 2024

The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018. June 2, 2024

Microbiologist in the Clinic: Postmenopausal Woman with Chronic OAB and Positive Urine Culture. May 31, 2024

New TENSI+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study. May 31, 2024

Outcomes of para-sacral transcutaneous electric nerve stimulation in treatment of primary and refractory overactive bladder among children. May 19, 2024

Page 4 of 121